Patents by Inventor Claudine Sharon Bonder

Claudine Sharon Bonder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240110915
    Abstract: The present disclosure relates to methods, products and systems for the prognosis of subjects suffering from multiple myeloma. In certain embodiments, the present disclosure provides a method of prognosis for a subject suffering from multiple myeloma. The method comprises determining the level of desmoglein 2 (DSG2) in malignant plasma cells from the subject, wherein an increased level of DSG2 in the plasma cells is indicative of a poorer prognosis for the subject.
    Type: Application
    Filed: November 16, 2021
    Publication date: April 4, 2024
    Applicants: University of South Australia, Central Adelaide Local Health Inc, The University of Adelaide
    Inventors: Craig Thomas Wallington-Beddoe, Claudine Sharon Bonder, Lisa Michelle Ebert
  • Patent number: 11000634
    Abstract: The present disclosure relates to medical devices using coated polymers, methods for reducing platelet attachment and/or fouling associated with medical devices, and methods for coating polymers. Certain embodiments of the present disclosure provide a medical device comprising one or more polymeric materials coated with a hyperbranched polyglycerol.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: May 11, 2021
    Assignees: AUSHEALTH CORPORATE PTY LTD, UNIVERSITY OF SOUTH AUSTRALIA
    Inventors: Eli Moore, Glen Leon Benveniste, Claudine Sharon Bonder, Nicolas Hans Voelcker
  • Patent number: 10994059
    Abstract: The present disclosure relates to anti-fouling and/or anti-thrombotic medical devices, methods for reducing fouling and/or thrombosis associated with medical devices, and methods for coating substrates to reduce fouling and/or thrombosis. Certain embodiments of the present disclosure provide an anti-fouling and/or anti-thrombotic medical device comprising a metallic substrate comprising a hyperbranched polyglycerol coating.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: May 4, 2021
    Assignee: TEKCYTE PTY LTD
    Inventors: Eli Moore, Nicolas Hans Voelcker, Claudine Sharon Bonder
  • Publication number: 20190099524
    Abstract: The present disclosure relates to medical devices using coated polymers, methods for reducing platelet attachment and/or fouling associated with medical devices, and methods for coating polymers. Certain embodiments of the present disclosure provide a medical device comprising one or more polymeric materials coated with a hyperbranched polyglycerol.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 4, 2019
    Inventors: Eli MOORE, Glen Leon BENVENISTE, Claudine Sharon BONDER, Nicolas Hans VOELCKER
  • Publication number: 20190076585
    Abstract: The present disclosure relates to anti-fouling and/or anti-thrombotic medical devices, methods for reducing fouling and/or thrombosis associated with medical devices, and methods for coating substrates to reduce fouling and/or thrombosis. Certain embodiments of the present disclosure provide an anti-fouling and/or anti-thrombotic medical device comprising a metallic substrate comprising a hyperbranched polyglycerol coating.
    Type: Application
    Filed: March 17, 2017
    Publication date: March 14, 2019
    Inventors: Eli MOORE, Nicolas Hans VOELCKER, Claudine Sharon BONDER
  • Publication number: 20170218340
    Abstract: A method for producing a population of cells, enriched for non-adherent endothelial progenitor cells (EPCs), the method comprising culturing an EPC containing population of cells in the presence of interleukin-3 (IL-3), such that a population of cells enriched for non-adherent EPCs is produced.
    Type: Application
    Filed: May 11, 2015
    Publication date: August 3, 2017
    Inventors: Claudine Sharon Bonder, Angel Francisco Lopez
  • Publication number: 20160053318
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: September 4, 2015
    Publication date: February 25, 2016
    Applicant: Medvet Science Pty Ltd.
    Inventors: CLAUDINE SHARON BONDER, Angel Francisco Lopez, Gert Hoy Talbo
  • Publication number: 20130224116
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: November 7, 2011
    Publication date: August 29, 2013
    Applicant: TransBio Ltd.
    Inventors: Claudine Sharon Bonder, Angel Fransciso Lopez, Gert Hoy Talbo